All Episodes
Journal of Clinical Oncology (JCO) Podcast — 462 episodes
Phase 2 Study of Multi-Cancer Detection from Breath Samples
JCO at ASCO 2026: Individualized Neoantigen Therapy Plus Pembrolizumab in Melanoma
JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma
JCO at ASCO 2026: Individual Patient Pooled Analysis of Low-Dose Tamoxifen in DCIS
JCO at ASCO 2026: Neoadjuvant Sacituzumab in MIBC
JCO at ASCO 2026: Intravesical Recombinant BCG with Chemo-Immunotherapy in MIBC
Adjuvant Durvalumab and the Future of Early-Stage NSCLC
JCO Article Insights: LEAP-010 Study in Recurrent/Metastatic Head and Neck Cancer
Infections in Two Diet Strategies in HSCT and Leukemia Patients
JCO Article Insights: ctDNA in DLBCL - Ready for Prime Time?
The CISTO Study: Radical Cystectomy or Bladder-Sparing Therapy for Recurrent NMIBC
JCO Article Insights: Atezolizumab, Bevacizumab, and Non-Platinum Chemotherapy for PROC
JCO Article Insights: Ribociclib Plus Letrozole in Recurrent LGSOC: GOG 3026
NCI Working Group on Biochemically Recurrent Prostate Cancer
Association Between EOL SACT and Healthcare Utilization
Milan Consensus Endpoints for Bladder Preservation in MIBC
JCO at 2025 ASH: Pirtobrutinib in Untreated CLL
JCO at ASH 2025: A New Validated Staging System for AL Amyloidosis: AL-ISS
JCO Article Insights: Simultaneous Durvalumab and CRT in Unresectable Stage III NSCLC
Health Outcomes in Older Childhood Cancer Survivors
Long-Term Remission After Cilta-cel in Patients With RRMM
JCO Article Insights: Xevinapant Plus Chemoradiotherapy in Unresected LA SCCHN
Income Among Adolescents and Young Adults Surviving Cancer
JCO Article Insights: Phase I DLL3/CD3 T-Cell Engager in DLL3-Positive SCLC or NECs
TTFields in Locally Advanced Pancreatic Adenocarcinoma
JCO at WCLC: Multinational Pivotal Study of Sunvozertinib in Exon20ins NSCLC
Racial and Ethnic Disparities Among Medicare Beneficiaries
JCO Article Insights: Lymph Node Dissection for Lung Cancer
JCO Article Insights: IMS-IMWG Consensus on High-Risk Multiple Myeloma
JCO Article Insights: Pooled Taletrectinib Efficacy and Safety
JCO at ASCO Annual Meeting: Neoadjuvant Osimertinib for Resectable EGFR-Mutated NSCLC
JCO at ASCO Annual Meeting: Use of Low-Value Cancer Treatments in Medicare
JCO at ASCO Annual Meeting: Avelumab Plus Cetuximab vs. Avelumab in Advanced cSCC
JCO at ASCO Annual Meeting: TTFields in Locally Advanced Pancreatic Adenocarcinoma
JCO at ASCO Annual Meeting: Lenvatinib Plus Pembrolizumab and Chemotherapy in Gastric Cancer
JCO Article Insights: Double Hit Myeloma Correlates With Adverse Patient Outcome
Pembrolizumab and Bevacizumab for Melanoma Brain Metastases
JCO Article Insights: ESPAC4 Long-Term Follow-Up in Pancreatic Cancer
Longitudinal Results from the Nationwide Just ASK Initiative to Promote Routine Smoking Assessment
JCO Article Insights: Smoking Assessment
Botensilimab Plus Balstilimab in Advanced Sarcomas
JCO Article Insights: Long-Term Outcome of Neoadjuvant Chemotherapy for Rectal Cancer
High Omega-3, Low Omega-6 Diet with Fish Oil and Prostate Cancer
JCO Article Insights: TROPION-Lung01 Dato-DXd in NSCLC
Air Pollution and Breast Cancer Incidence
JCO Article Insights: Adoption of Capivasertib in Metastatic Hormone Receptor–Positive, HER2-Negative Breast Cancer – Efficacy, Toxicity and Treatment Sequencing
Overcoming Barriers to Make Patient-Partnered Research a Reality
JCO Article Insights: Nivolumab + Relatlimab v Nivolumab + Ipilimumab in Melanoma
Quality of Treatment Selection
JCO Article Insights: HLA-Mismatched Unrelated Donor HCT With PTCy
Adjuvant Pembrolizumab for High-Risk, dMMR Endometrial Cancer
Combining Response and Toxicity Data to Implement Project Optimus
CBT-I for Cancer-Related Cognitive Impairment
JCO Article Insights: Assisted Reproduction in Breast Cancer Patients
Multi-Cancer Early Detection Testing for High-Risk Patients
JCO Article Insights: Back to the Drawing Board: Overcoming Resistance to PD-1 Blockade
Functional Disability Among US Cancer Survivors
CAR T-Cell Therapy for Richter's Transformation
EAZ171: Predictors of TIPN in Black Women with Breast Cancer
JCO Article Insights: Final Analysis of the Ro-CHOP Trial
Methylphenidate for Fatigue in Advanced Cancer
Introducing JCO Oncology Advances with Dr. Jonathan Friedberg and Dr. Pamela Kunz
JCO Article Insights: Atezolizumab Plus Bevacizumab, Chemotherapy in EGFR, ALK NSCLC
Commonly Held Beliefs About Cancer Survivorship
JCO Article Insights: Long Term Follow Up of the RESORT (E4402) and LYSA Study
Pembrolizumab in Patients With Advanced Cancers With HTMB
JCO Article Insights: Axillary Soft Tissue Involvement and Breast Cancer Prognosis
Omission of Radiotherapy after Breast-Conserving Surgery
Costs of Cancer Prevention in CDH1 Variant Carriers
JCO Article Insights: Low and Moderate Grade Adverse Events and the Patient Experience in Clinical Trials
Debunking Sex and Disentangling Gender From Oncology
Germline EGFR Mutations and Familial Lung Cancer
JCO Article Insights: DYPD-Guided Dose Individualization and Survival Outcomes
Negative Impact of Prior Authorization on Patients with Cancer
Role of Molecular Classification in Predicting Response to Radiation in Early Endometrial Cancer
JCO Article Insights: Impact of Physical Activity on Mortality and of BMI on Treatment-Related Adverse Events
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
JCO Article Insights: Safety and efficacy of a Novel ADC Targeting TROP-2 in Metastatic Non-Small Cell Lung Cancer (NSCLC)
Economic Evaluation of a Non-Medical Financial Assistance Program on Missed Treatment Appointments Among Adults With Cancer
Disparities in End-of-Life Cancer Care
Advance Care Planning in Adolescents and Young Adults with Cancer
JCO Article Insights: Improving Lung Cancer Screening Using Blood-Based Biomarkers
Impact of Smoking Cessation on Mortality From Kidney Cancer
HER3-DXd in EGFR-Mutated NSCLC: HERTHENA-Lung01
JCO Article Insights: Introducing The Childhood Cancer Data Initiative
Impact of Heatwaves on the Care of Patients With Cancer
JCO Article Insights: Immunotherapy in People Living with HIV and Cancer
Racial/Ethnic Differences Discovered in Multigene Germline Testing of Early-Onset Colorectal Cancer
JCO Article Insights: Two New Prediction Models for Risk of Venous Thromboembolism in Cancer Patients
Olanzapine for Chemotherapy-Related Anorexia
PROSPECT Trial (Alliance N1048): PROs During and After Treatment for Locally Advanced Rectal Cancer
JCO Article Insights: Smoking Cessation for Patients with Cancer
JCO Article Insights: Use of Independently-Assessed vs Investigator-Assessed DFS in the APACT Trial
Peritumoral Anesthetic Infiltration Impacts Survival in Early Breast Cancer
Intensive Caring: Reminding Patients They Matter
Barriers to Clinical Trial Participation for Transgender People
JCO Article Insights: Trial Update on Development of Children After Maternal Cancer During Pregnancy
Cancer Screening During the 2nd Year of the COVID-19 Pandemic
Sequencing Matters – Combination Dabrafenib/Trametinib Versus Nivolumab/Ipilimumab for Advanced BRAF-Mutant Melanoma: The DREAMseq Trial
JCO Article Insights: Phase III POSEIDON Clinical Trial Results
One-Stop-Shop Comprehensive Cancer Screening Center Focused on Asymptomatic Screening
Improving Transparency in Phase 1 Clinical Trials
JCO Article Insights: Elderly Patients Receiving Chemotherapy for Early-Stage Breast Cancer
Ensuring Employment After Cancer Diagnosis
Intersectional Maxims for a New Era in Modern Medicine
Does Medicare Advantage Lead to a Disadvantage for Patients Who Need Surgery for Cancer?
Lack of Gender Equity in Oncology Clinical Trial Advisory Board Membership
Universal Germline Genetic Testing in GI Malignancies
Light From Darkness - Navigating Postmortem Tissue Donation
Physical Activity Improves Survival in Colorectal Cancer
Food Insecurity Interventions for Cancer Survivors With Dr. Francesca Gany and Dr. Theresa Hastert
How to Confront Climate Change: A Framework for Change in the Operating Room and Hospital as a Whole. A Conversation with Dr. Anaeze Offodile and Dr. Elizabeth Yates
JCO After Hours: A Discussion With Veena Shankaran and Scott Ramsey
JCO After Hours: A Discussion With Virginia Sun
JCO After Hours: A Discussion With Antonio Di Meglio
JCO After Hours: A Discussion With Abby Rosenberg and Reshma Jagsi
JCO After Hours: A Discussion With Michael Gnant and Kathy Miller
JCO After Hours: A Discussion With Kirsten Beyer and Jennifer Griggs
Is Dose-Adjusted EPOCH-R the Optimal Treatment for Children with Primary Mediastinal B-Cell Lymphoma?
Steroid Dose and Taxanes
Commentary on GROINSS VII
Harnessing the Power of Registries to Understand the Impact of Treatment for Hodgkin Lymphoma on Fertility
Subspecialty Palliative Care Involvement May Lessen the Need for High-Intensity End-of-Life Care for Adolescents and Young Adults With Cancer
Can the Incorporation of Minimal Residual Disease Detection Enhance Post-CAR T Outcomes in Patients With Large B-Cell Lymphoma?
Moving Forward With Venetoclax-Based Combinations in Younger Adults With Acute Myeloid Leukemia
A Deep Dive Into HLA Typing For Unrelated Donor Hematopoietic Cell Transplantation
PENELOPE-B: Exploration of CDK4/6 Inhibition in the Adjuvant Setting
ctDNA in DLBCL: A Blueprint for Better Clinical Trials?
How Can We Expand Eligibility Criteria for Diffuse Large B-Cell Lymphoma Clinical Trials to Serve More Patients?
The Pathologist, the Surgeon, and the Rare Phyllodes Tumor
Cancer Surgery in COVID-19-Free Facilities
Finding a Needle in a Haystack of Mutations: Using Whole Genome Sequencing to Identify Patients with Low-Risk Myeloma
Advancing Knowledge on the Use of Dexrazoxane in Children With Acute Myeloid Leukemia and Other Childhood Cancers
Better Diet – Fewer Side Effects?
Genetic Testing in Breast Cancer Patients: Striking the Balance Between Over Versus Undertesting
High Reward, High Toxicity: Combination Pembrolizumab and Lenvatinib in Advanced Endometrial Cancer
Optimizing Treatment Strategies for Germline BRCA/PALB2 Mutant Pancreatic Adenocarcinoma
Immune Checkpoint Inhibitor Use in Patients With Inflammatory Bowel Disease: A Closer Look
The High Prevalence of Exercise Intolerance in Adult Survivors of Childhood Cancer Is Predictive of All-Cause Mortality
Leptomeningeal Disease in EGFR-Mutated Lung Cancer: Can We Finally Define a Standard Treatment?
Advancing Treatment Options for Mismatch Repair-Deficient Metastatic Colorectal Cancers
Keeping Mycosis Fungoides in Check: A Study of Pembrolizumab for Relapsed/Refractory MF and Sezary Syndrome
What's in a Name? An Introductory Guide
Resuming Life After Cancer Therapy: Treatment-Free Survival
Intratumoral Immune Infiltration in Follicular Lymphoma: Novel Insights into Early Relapse and Survival
MYC Rearrangements in Diffuse Large B-Cell Lymphoma: Impact and Implications for Diagnostic Testing
Centralization of High-Risk Surgery: Real Benefits for Patients From Health Systems
Microsatellite Instability as a Prognostic Marker for Resectable Gastric Cancer and a Potential Biomarker for Perioperative Chemotherapy Benefit
Radiotherapy Dose Reduction Is Possible With Induction Chemotherapy for Pediatric Nasopharynx Cancer
Fine Tuning Therapy for Intermediate-Risk Neuroblastoma Using Clinical Response and Tumor Biology
Déjà Vu or Predicted: The Failure of Dose Adjusted EPOCH-R to Improve Outcomes in Diffuse Aggressive Lymphomas
Tackling Stage III EGFR Mutation-Positive Lung Cancer: Do We Really Know How?
The Need for Continued Vigilance in Patients with Diffuse Large B-Cell Lymphoma
A Second Chance at Checkpoint Inhibition After Initial Immune-Mediated Diarrhea and Colitis
Anticipating the Future of Hodgkin Lymphoma
An Advance for the Treatment of Osteosarcoma
The Heartbreak of Cancer Treatment: The Latest in Late Cardiac Toxicity
Programmed Cell Death-1 Pathway Inhibitors Enter Center Stage as First-Line Treatment of Advanced Merkel Cell Carcinoma
Potential for Parenthood After Childhood Cancer: Perceptions and Reality
How Should We Interpret Indeterminate Pulmonary Nodules at Diagnosis in Children With Rhabdomyosarcoma?
The End of ENDoxifen Metabolite and CYP2D6 Testing in Tamoxifen-Treated Women?
Less is More: Precision Surveillance Imaging for Wilms Tumor
How Low Can You Go? Impact of Baseline Corticosteroid Use on Immunotherapy Outcomes in Patients With Advanced Non-Small-Cell Lung Cancer
Expanding Treatment Options for Hormone Receptor-Positive, HER2-Positive Metastatic Breast Cancer
The Addition of Another Camptothecin Fails to Improve Outcomes in Patients With Intermediate-Risk Rhabdomyosarcoma
The Addition of IKZF1 Deletion in Risk Stratification for Children with Newly Diagnosed B-Acute Lymphoblastic Leukemia Leads to Improved Survival: Results of the Malaysia-Singapore ALL 2010 Study
Psychosocial Outcomes Following Contralateral Prophylactic Mastectomy: Insights and Opportunities
Risky Business: PD-1 Immune Checkpoint Blockade in Thymic Epithelial Neoplasms
Don't Treat Me Like a Child: The Intensification of Conventional Chemotherapy in Adults With Acute Lymphoblastic Leukemia
Multiple Myeloma Joins the Car T Race
Cardiotoxicity After Breast Cancer Radiotherapy: Which Part of the Heart Matters Most?
Should Prophylactic Cranial Irradiation Be Used in Patients with Stage III Non-Small Cell Lung Cancer?
The Medical Marijuana Conundrum: When Public Interest Outpaces Medical Knowledge
Racial Disparities in Medical Financial Hardship Among Cancer Survivors
Late Infectious Death: Asplenic Adult Survivors of Child Cancer
Extending the Reach of Targeted Therapy for Hormone Receptor-Positive Advanced Breast Cancer
An International Phase II Trial of Single-Agent Nivolumab for Hodgkin Lymphoma Relapsed or Refractory After Autologous Stem Cell Transplant
Exploring a New Delivery Model for Germline Genetic Testing for Patients With Ovarian Cancer
Is Earlier Treatment Better For Patients? The Case of Docetaxel in Metastatic Castration-Sensitive Prostate Cancer
The Decision to Image Breast Cancer Patients with Local-Regional Recurrence
The Importance of Reading Clinical Trial Protocols Simultaneously With Published Studies
Understanding the 'Value-Added' by Specialized Pediatric Palliative Care Teams in the Care of Children With Cancer at the End of Life
Survival Following Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Early-Stage Hepatocellular Carcinoma
The True Costs of the 21-Gene Assay in a Cohort of 1,000 Patients
Persistent Use of Opioids After Cancer Surgery
Discussion on the Cost–Effectiveness Analysis of the CALGB/Alliance Trial and the Use of Zoledronic Acid Generic in Women With Metastatic Breast Cancer
Can We Simplify the Treatment of Myelofibrosis?
Lessons to be Learned about the Significance of Educational Level in Adults with Acute Myeloid Leukemia
More Often but Not Early: Hospice Use Among Older Adults With AML
T-cell Therapy for Viral Infections after Stem Cell Transplant
Shared Risk Factors in Cancer and Cardiovascular Disease: Can We Make a Difference?
Should Metabolic Imaging to Assess Minimal Residual Disease (MRD) Become a Clinical Endpoint in Multiple Myeloma?
Considerations in Predicting Neuropsychological Outcomes in Children Treated for ALL
Low-Income Subsidy and Financial Barrier to Access Costly Oral Chemotherapy Drugs for Myeloma Patients Enrolled in Medicare Part D
Beyond the Beam: Thinking about Subsequent Malignancy Risk Outside of the Radiation Paradigm,"
Discussion of the SWORD-Study and Fear of Cancer Recurrence Intervention Research Randomized Controlled Trial
Optimizing Up-Front Therapy for Double-Hit Lymphoma
Chronic Conditions in Cancer Survivors
Do Treatment Summary Survivorship Plans Make Any Difference?
The Impact of Cigarette Smoking on Survival in Patients with Pancreatic Cancer
Better Patient-Reported Outcomes After Autologous Breast Reconstruction Compared to Implant-Based Reconstruction Study
Drugs Don't Work in Patients Who Don't Take Them
Pembrolizumab is Safe and Active in Platinum- and Cetuximab-Refractory Head and Neck Squamous Cell Carcinoma
Long-Term Follow-up of AF-001JP: A Phase I/II Study of Alectinib in ALK-Positive NSCLC
Late Relapse in Hodgkin Lymphoma Persisting Even at 20 Years: Implications for Therapeutic Intensity and Disease Biology
Intensification of Consolidation Therapy for Acute Myeloid Leukemia by the Addition of Clofarabine to Cytarabine Improves Relapse-Free Survival
Characterizing the Patterns of Clonal Evolution in Ibrutinib-Treated CLL: A Roadmap for Continued Progress
Prevalence of Germline Mutations in Individuals With Colorectal Cancer as Determined Using a Multi-Gene Panel Test
Financial Barriers to Cancer Care for Patients Obtaining Insurance on the Federal Exchange
Mindfulness-Based Interventions in Oncology: Not for Everyone?
The Impact of Oral Targeted Therapies on the Cost of Care for Patients With Chronic Lymphocytic Leukemia
Watching Nivolumab's Balancing Act: How Immune Activation May Affect Both Safety and Efficacy in Patients With Advanced Melanoma
Getting to the Heart of the Matter: Biomarkers for the Assessment of Trastuzumab-Induced Cardiac Dysfunction
Listen to Your Patients
Impact of Organizational Characteristics and Process of Care on Hospital Mortality and Resource Use in Cancer Patients Admitted to Intensive Care Units
Health-Related Quality of Life: Increasingly Important in the Era of Effective, Modern Myeloma Therapy
Chemotherapy Induced Peripheral Neuropathy: A Novel Method of Exploration
Changes in the Epidemiology of AIDS-Related Kaposi's Sarcoma and Lymphomas: How This Informs the Clinician
Implicit Racial Bias Affects Key Aspects of Physician Communication
Nivolumab Monotherapy is Safe and Active in Hematologic Malignancies
Minimizing Frailty in Cancer Survivors: A Meaningful Goal for All Ages
1q Gain, a Prognostic Biomarker in Nephroblastoma, and What's Next?
Therapy Impacts Long-Term Survival for Patients in Germany With Heritable Retinoblastoma
Dexamethasone and High-Dose Methotrexate in High-Risk B Cell Acute Lymphoblastic Leukemia—Where Should We Go From Here?
Unraveling the Significance of Mismatch Repair Deficiency in Women With Endometrioid-type Endometrial Adenocarcinoma
Nodal Status After Neoadjuvant Chemotherapy Determines Prognosis in Localized Gastric Cancer
Restrictions on Nutrition, Social Contacts, and Pets Are Not Effective Anti-Infective Measures in Children With Acute Myeloid Leukemia
Current Status of Supplemental Screening in Dense Breasts
Selective Internal Radiation Therapy for Liver-Dominant Metastatic Colorectal Cancer: Time to Put the Brakes On?
Prognostication Based on Site of Metastatic Disease in Castration Refractory Prostate Cancer: Implications for Patient Care and Clinical Trial Design
IgM-Related AL Amyloidosis: A Rare Form of a Rare Disease
Quality of Life: A Critical Consideration in Women Diagnosed with Ductal Carcinoma in Situ
Very Late Outcomes of Wilms Tumor Survivors: British Childhood Cancer Study
Web-Based Technology Can Improve Patient Understanding and Preparedness to Discuss Cancer Clinical Trials: One Step Towards a Goal of Increased Enrollment
How Should We Manage the Financial Toxicity of Cancer Treatment?
Prognostication in Mantle Cell Lymphoma
Sunbelt Melanoma Trial: A Seminal Adjuvant Interferon Trial with Long Term Results
Hepatocellular Carcinoma in Children and Adolescents: Time for a Strategy and a Trial
Clinical Drug Development for Non-Muscle-Invasive Bladder Cancer…Definitions Matter
Race for the Cure: How differences in Race and Ethnicity Impact the Diagnosis and Survival of T-Cell Lymphoma
Epidural Spinal Cord Compression: The Importance of Multi-disciplinary Treatment Planning
Hard to RECIST: Updating and Simplifying Primary Tumor Response Guidelines for the Revised International Neuroblastoma Response Criteria (INRC)
Expanding Immunotheapy Benefit in Metastatic RCC
A New Oncogene Target in Lung Cancer: Exon 14 Alterations in the MET Gene
The Evolution of the Polycythemia Vera Symptom Burden: Implications for a Changing Treatment Paradigm
The Emerging Role of Gallium-68 Somatostatin-Receptor PET Imaging in Neuroendocrine Tumors
Dexrazoxane for childhood cancer patients – ready for prime time?
Uterine lavage: a new approach to gynecologic cancer detection?
Hormonal Therapy is Out for Meningiomas: Time to Change Tactics?
Defining the Optimal Interval for Colonoscopic Screening in Individuals with a Family History of Colorectal Cancer
Using the CLIC Study of Outcome in Advanced Stages of Mycosis Fungoides and Sezary Syndrome to Guide Treatment And Clinical Research
Geographic Access as a Barrier to Adjuvant Chemotherapy for Patients with Stage III Colon Cancer
Host Factors and Lynch Syndrome Patients: Weighing Role of Obesity and Aspirin and Risk of Colorectal Cancer
To Stop or Not to Stop: That is the Question
Breast Cancer and Weight Loss: Where Do We Go from Here?
The Promise and the Pitfalls of Population-Wide Screening of BRCA1 and BRCA2
Intraperitoneal Therapy for Ovarian Cancer: No More Excuses
Balancing Safety and Efficacy in the Treatment Hodgkin Lymphoma: Early Discontinuation of Certain Drugs Can and Should Be Done
When Toxicity and Efficacy Collide
First Results of Euramos I and Logistics of International Collaboration for Clinical Trials of Rare Diseases
Treatment Advances in Local-Regionally Advanced and Stage IVB/Recurrent Cervical Cancer: Can We Agree that More Isn't Always Better?
Androgen Deprivation Therapy for Prostate Cancer - Friend or Foe to the Psyche?
Building Blocks in the Case for Adjuvant Therapy in Biliary Tract Cancers
Aromatase Inhibitor Arthralgias: Identification, Treatment Options and Research Perspectives
Deciphering the Heterogeneity Within EGFR-mutant Lung Cancer
Precision Immunology: The Promise of Tumor Immunotherapy for the Treatment of Cancer
The Importance of Discussing Genetics with Every Breast Cancer Patient
Hematopoietic Stem Cell Transplant for Children With Acute Lymphoblastic Leukemia at BFM Centers: Comparable Results With Matched Sibling Donors and Matched Unrelated Donors
Is It Biology or Brawn in Ovarian Cancer Surgery?
Mirror Views: Reflections of Complementary Perspectives in Patient and Clinician Toxicity Reporting
Dynamic Evolution of ALK Positive Non-Small Cell Lung Cancers and Management of Associated Brain Metastases
Prediction of Breast Cancer Risk After a Benign Breast Biopsy: A Practical Model?
Prophylactic Anticoagulation in High-Risk Metastatic Germ Cell Tumor Patients: Who Should We Treat?
The Risk of Second Cancers for Patients with Endometrial and Rectal Cancer Receiving Radiation Therapy
Better Outcome of Chemo-Irradiation of Head and Neck Cancer in High-Patient-Volume Institutions
Is There a Future for Cyclooxygenase-2 Inhibition in Non-Small Cell Lung Cancer?
The Treatment of Insomnia in Cancer Patients
The Biopsy Study: How the Use of Multiple Colposcopic-Directed Biopsies Improves Detection of Cervical Precancers
Intensified Frontline Chemoimmunotherapy with R-ACVBP May Improve Outcomes for Younger Patients with Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma
A Positive Study of DTC-Guided Secondary Adjuvant Treatment in Early Breast Cancer: Ready for Prime Time?
A Second Course of Radiation Therapy for Painful Osseous Metastases Improves Patient Function and Quality of Life
Adjuvant Trastuzumab Passes the Test of Time
Prognostic Value of BRAF V600 E Mutation in Papillary Thyroid Cancer
Biochemotherapy: As Time Goes By?
The First Prospective Trial of Proton Therapy for Children With Rhabdomyosarcoma: What We Learn From Preliminary Results
Intermediate Risk Pediatric Hodgkin Lymphoma: Early Response-Adapted Treatment Is Key
Keeping Older Cancer Patients out of the Hospital: A Community Affair
Optimal Duration of MRD Monitoring During Therapy for Childhood ALL
Hepatitis B Reactivation in Patients Receiving Rituximab Can Be Detected Early and Managed with Antivirals
CT or No CT: An Important Question in Diffuse Large B-Cell Lymphoma
Glembatumumab Vedotin (CDX-011, CR011-vcMMAE): On The Brink Of Targeted Therapy For Triple-Negative Breast Cancer?
Post-Transplant Cyclophosphamide for GVHD Prophylaxis: Back to the Future
The Price Of A Drug is Not the Whole Cost
Cabozantinib in Advanced Prostate Cancer: Is the Therapeutic Window Too Narrow?
Fracture Risk after Cystectomy: Don't Ignore It
Is Hematopoietic Stem Cell Transplantation of Value in Treating Systemic Mastocytosis?
Significant Dose Effect of Radiotherapy to the Pancreas and Risk of Diabetes Mellitus in Long-Term Hodgkin Lymphoma Survivors
The End of Rituximab Maintenance for Low Tumor Burden Follicular Lymphoma
Use of Mutational Analysis to Help Decide Whether Patients with Myelodsysplastic Syndromes Should Receive Allogeneic Hematopoietic Cell Transplant
Why are Fellows' Burnout Rates as High as Those of Practicing Oncologists?
Surprisingly Good Results in BCR-ABL1-like Pediatric Acute Lymphoblastic Leukemia: What Do They Mean?
Should Corticosteroids Be Used for the Treatment of Pain, Fatigue and Loss of Appetite in Cancer Patients Receiving Opioids?
Breast Reconstructions: Inequities in Access Affecting Choice and Quality
Recurrent/Metastatic Human Papillomavirus-Associated Oropharynx Cancer: What Happens When This Good Prognostic Cancer Misbehaves?
Long Term Cardiac Safety Data from the HERA Adjuvant Trastuzumab Trial
Breast Needle Core Biopsy: The Impact Surgeons and Geography Have on Utilization and the Impact on Patient Care
Identifying High-Risk Myeloma
Attempting to Avoid Chemotherapy in CLL with Lenalidomide and Rituximab
Breast Cancer Chemotherapy Effects on Brain Activation During Multitasking and Relation to Cognitive Complaints
Delayed Diagnostic Lumbar Puncture to Optimize Central-Nervous-System-Directed Therapy in Childhood Acute Lymphoblastic Leukemia
Capecitabine Versus Continuous Infusion 5-FU for Rectal Cancer Neoadjuvant Chemoradiation: Equivalent Effectiveness Raises Real-World Questions About Efficacy, Adherence and Economic Implications
Evolving Treatment Paradigms for Primary Mediastinal Diffuse Large B-Cell Lymphoma
Response Assessment in Hodgkin Lymphoma: Size Matters!
Second Tumors in PTEN Mutation-Positive Patients: Are They Recurrences or New Primaries?
Are Partners of Patients HPV-Positive Oropharyngeal Cancer at Increased Risk of Infection and Cancer?
Planning to Survive: The Role of Physicians
Minimal Residual Disease (MRD) Study to Optimize Definition and Therapy of High-Risk Acute Lymphoblastic Leukemia
Risk-Reducing Oophorectomy in Women with BRCA1 and BRCA2 Mutations: An Opportunity to Personalize Recommendations for Cancer Prevention
Anti-EGFR Monoclonal Antibodies in the First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The PEAK Experience
Accuracy of BRCAPRO in Women with Ovarian Cancer
Serious Bevacizumab-Associated Gastrointestinal Toxicity
The Efficacy of Bevacizumab Combined with Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer Patients and Its Effects On Patient-Reported Outcomes
Nivolumab: Promising Survival Signal Coupled with Limited Toxicity Raises Expectations
Decision Shared or Otherwise-: The Ongoing Evolution of Local Therapy for Breast Cancer
Is Early Initiation of Adjuvant Chemotherapy for Breast Cancer Better?
Single Agent Rituximab Active in Nodular Lymphocyte Predominant Hodgkin Lymphoma
Adjuvant Treatment for Gastric Cancer: The Story Continues to Evolve
Benefits of Modified Craniospinal Radiation Therapy for Children Treated for Medulloblastoma: Preserving Long-Term Neurocognitive Function
Breast MRI As It Is, In Contrast To How We Wish It To Be
New Adoptive T Cell Therapy Has EBV-Positive Lymphomas on the Run
Adjuvant High-Dose Interferon: New Evidence Regarding Treatment Duration and Survival Impact in Melanoma
Some like It Even Hotter: Escalating Radioimmunotherapy in Follicular Lymphoma?
Increasing Cytarabine Dose in AML Induction Improves Outcomes in Younger Patients
The Value of Preoperative MRI in Predicting Outcome in Patients with Rectal Cancer
Refining Stringency of Response in Myeloma
When Hodgkin Lymphoma Relapses in The Older Patients
How Do We Decide Who Should Be Offered a Sentinel Node Biopsy When Their Melanoma Is Less than 1mm in Thickness?
FISH for Smoldering Multiple Myeloma
External Beam Accelerated Partial Breast Irradiation: Exploring the Limits of Tolerability
Minimal Residual Disease (MRD) in Acute Myeloid Leukemia- Are we Ready for Individualized Risk Assessment Based on MRD?
Functional Imaging as a Biomarker for Survival in Locoregionally Advanced Non-Small Cell Lung Cancer Patients
EORTC 18961 GMK Vaccine Adjuvant Trial: Unfulfilled Promise for Another Vaccine Trial
Lenalidomide Monotherapy for Relapsed Mantle Cell Lymphoma
Flying Solo: Chemotherapy Without Radiation for Primary Central Nervous System Lymphoma
Second Hematopoietic Transplants for Relapsed AML
In End-Of-Life Decision-Making, Does DNR Measure Up?
A Clear Answer to the Wrong Question
Bisphosphonate-Related Osteonecrosis of Jaw (BOJN) in the Adjuvant Breast Cancer Setting: Risks and Perspective
Should Myeloma Residual Disease Become a Standard Assay for Large Cooperative Groups and Myeloma Referral Centers?
The Prognosis of Breast Cancer Diagnosed During Pregnancy
The SUCCEED Trial: Maintenance Ridaforolimus for Metastatic Soft- Tissue Sarcomas
Who Needs What Therapy? The Elusive Search for Predictive Markers
Micro RNAs and Other Molecular Markers in AML Therapeutics
Neuroanatomic and Neuropsychological Outcomes in Adults after Treatment for Childhood Acute Lymphoblastic Leukemia
HERA Indicates that Adjuvant Trastuzumab Confers Equal Benefit for HER2-Positive Invasive Ductal and Invasive Lobular Breast Cancers
New Evidence of the Clinical Significance of Cigarette Smoking by Colon Cancer Patients
Radiotherapy for Pediatric Hodgkin Lymphoma: Are We Ready To Say Goodbye?
Minimal-Intensity Conditioning: A Decade Later
Evolution of Concurrent Chemoradiation Treatment Approaches in Head and Neck Cancer
Off-Label Cancer Therapy Use: How Much is Too Much?
Caring For Patients With Transformed Follicular Lymphoma
Outpatient Therapy for Fever and Neutropenia is Safe But Implementation is the Key
Outcomes in Cancer Survivors Who Develop Second Malignant Neoplasms
Molecular Profiling of Gastric Cancer: Toward Personalized Cancer Medicine
Reflections on "Cancer Survivorship": Evolution, Utility, and Acceptability
Estimating the Risk for Contralateral Breast Cancer as a Guide for Surgical Treatment
Revisiting Combination TACE-RFA Treatment for HCC
Novel Insights From a Phase II MEK Inhibitor Trial in BRAF Mutant Melanoma
Successful Non-Intensive Bridging of MDS Patients Towards Allografting
Using a Video Decision Support Tool for CPR Decision-Making
Radioimmunotherapy for the Initial Treatment of Follicular Lymphoma
Management of Metastases to the Brain: A Therapeutic Conundrum
Understanding the Role of MET Kinase in Cancer Therapy
AIDS Related Lymphomas - More Options and More Questions
Long Term Follow-up of NSABP B-31: How Well Can We Predict Cardiac Toxicity with Trastuzumab?
More Adjuvant Chemotherapy is Not Always Better
Hodgkin Lymphoma: Protecting the Victims of Our Success
Beyond the Plasma Cell: Proteasome Inhibition in Acute Myelogenous Leukemia
Breast Brachytherapy in the United States: Increasing Use Despite Increased Complication Rates
Referral Practices to Palliative Care Among Canadian Oncologists
Clinical Utility of Screening Tests in Asymptomatic Long-Term Childhood Cancer Survivors
Is Lymphatic Mapping Ready for Clinical Use in the Treatment of Squamous Vulvar Cancer?
Rituximab Maintenance Therapy After Autologous Stem Cell Transplantation: Final Analysis of the CORAL Trial
Informed Consent for Pediatric Phase I Cancer Trials: An End-of-Life Decision
Outcome in Systemic Anaplastic Large Cell Lymphoma: Beyond ALK
Should Gemtuzumab Ozogamicin Be Re-added to the Therapeutic Armamentarium for Acute Myeloid Leukemia?
Immunohistochemical Double Hit Score in Diffuse Large B-Cell Lymphoma: The Potential to Screen All Tumors for High-Risk Biology
In a Sea of Data the Water is Still Murky: Meta-Analysis of Cognition in Breast Cancer
KRAS G13D Mutations in Metastatic Colorectal Cancer: Are They Different From Codon 12?
Taxane Induced Peripheral Neuropathy: A Continued Challenge but Not a Biomarker of Treatment Efficacy
Is This Nomogram Ready To Roll?
Adjuvant Chemotherapy in Older Patients with Stage III Colon Cancer
The Combination of Bortezomib, Thalidomide, and Dexamethasone in Relapsed Multiple Myeloma
Personalized Therapy for Breast Cancer: Is It Really Happening?
Routine Second Pathology Review for Node-Negative Breast Cancer: What is Learned and What is the Effect on Patient Care?
Pre-Operative Metformin in Early-Stage Breast Cancer
Fulvestrant and Anastrozole in Combination: FACT or Fiction?
A New Day Dawning for Hodgkin Lymphoma?
The German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow Up of 11 Years: Implications of Long Term Follow Up
Carboplatin-Gemcitabine-Bevacizumab: Expanding Treatment Options for Recurrent Platinum Sensitive Epithelial Ovarian Cancer
The Use of Adjuvant Therapy in Elderly Patients with Resected Non-Small Cell Lung Cancer (NSCLC)
Management and Prevention of Pain Related to Treatment or Disease
1 + 1 = 3. Combined Use of Anti-HER2 Agents in the Neoadjuvant Setting
Management of Low Stage Ovarian Clear Cell Carcinoma
Surviving Childhood Cancer: Defining Risk of Poor Cardiac Outcomes in Early and Middle Adulthood
No Advantage to Combining Cetuximab with 5FU, Leucovorin, and Oxaliplatin in Metastatic Colorectal Cancer
Sorting Through Early Melanomas to Identify Those at Higher Risk for Metastases
Sedation for the Management of Refractory Suffering
The Role of the Estrogen Receptor (ER) in Selecting Women, Diagnosed with DCIS for Adjuvant Therapy with Tamoxifen
How Cooperative Group Trials Impact Breast Cancer Care in United States
What's Different Between One Colorectal Cancer and Another? It's All in the Genes
Molecular Tumor Analyses Followed by First Line Oral Tyrosine Kinase Inhibitors in Lung Adenocarcinomas with Driver Abnormalities
Placing the P Value into Perspective: Does Paclitaxel Add Value to Gemcitabine and Cisplatin in Advanced Urothelial Cancers?
Early Stage Hodgkin Lymphoma -- How Much is Enough?
The Rich Get Richer: Another Efficacious Option for Refractory Hairy Cell Leukemia
Rethinking Our Use of CSFs in the Adjuvant Treatment of Women Who Have Estrogen Receptor Positive Cancers
Recurrence and Survival Results of the GOG Lap2 Trial Confirm Safety of the Laparoscopic Approach to Surgical Staging and Treatment for Uterine Cancer
"Anything You Can't Do, I Can't Do Either": Transplantation for High Risk AML
Safety and Efficacy of Sequential Adjuvant AI Therapy in ER Positive Breast Cancer
The Role of Ovarian Suppression for Fertility Preservation in Women Receiving Adjuvant Breast Cancer Chemotherapy
Using BCR-ABL Transcript Levels After 3 Months of Therapy on Imatinib is the Best Way to Predict Long-Term Outcome for Patients with CML Treated with Imatinib
The Importance of Tumor Biopsies for Analysis of Mechanisms of Response and Resistance in Prostate Cancer
Targeting the Angiopoietin-Tie2 Axis: A Promising Alternative Antiangiogenic Strategy for Epithelial Ovarian Cancer
Interim PET Scans in Diffuse Large B-Cell Lymphoma - More Than Another Biomarker?
To Biopsy or Not to Biopsy? That is the Question
Disparities in Systemic Therapy for Breast Cancer
Adjusting for Treatment Cross-Over to Enable Analysis of Longer Term Outcomes in the MA.17 Trial
Obesity and Colorectal Cancer: What's the Big Deal?
Combinations or Single Agents, Crossover or No Crossover: Considering Chemotherapy Strategies in the Multi-Chaptered Story of Metastatic Breast Cancer
Medical Oncologist Attitudes and Practice in Cancer Pain Management: A National Survey
Is a "Wait and See" Nonoperative Approach Justified after Chemoradiation for Rectal Cancer
Predictive Testing for BRCA1/2 Mutations: The Value of the "True"Negative
Trastuzumab in the Adjuvant Setting - Sequential versus Concurrent: Will We Ever Know the Full Answer?
Solving the Mystery of Recurrence in "Surgical Cures" for Early Non-Small Cell Lung Cancer
Comorbidity Data in Cooperative Trials: Feasible and Non Ignorable
Gender Equity and HPV-Associated Cancers in the United States
Biomarker Selection for Maintenance Therapy in Advanced NSCLC
Osteonecrosis in Pediatric Acute Lymphoblastic Leukemia
R-CHOP Chemotherapy as Upfront Treatment for Advanced Stage Follicular Non-Hodgkin Lymphoma
Venlafaxine and Clonidine for Treatment of Hot Flashes in Women with Breast Cancer
Response to Neoadjuvant Systemic Therapy for Breast Cancer in BRCA Mutation Carriers and Non-Carriers: A Single Institution Experience
Individualizing the Risk of Cardiovascular Mortality Following Androgen Deprivation Therapy for Prostate Cancer
High Risk Stage II Colon Cancer: What is the Role of Adjuvant Chemotherapy?
Is Genotype Guided Tamoxifen Dosing Ready for Prime Time?
Menopausal Hormone Therapy, Mammographic Density and Breast Cancer
The Growing Value of Risk Calculators for Men Considering Prostate Cancer Screening
Interpretation of the Biomarker Analysis and Final Overall Survival Results from IPASS
Curing Leukemia with a Single Drug
Vaccination with an Autologous Idiotype Based Vaccine Following a Chemotherapy Induced Remission Holds Promise in the Treatment of Patients with Follicular Lymphoma
Pathologic Complete Response and Toxicity Results from the STAR-01 Trial Evaluating the Addition of Oxaliplatin to Neodjuvant Chemoradiation for Locally Advanced Rectal Cancer
MEK Inhibitors
Angiogenic Therapy in Breast Cancer: Axitinib with Chemotherapy Joins the Crowd
Advanced Radiation Therapy Technology Improves Survival in Lung Cancer
The Dark Side of del(5q) MDS
Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer: Is it Ready for Prime Time?
Are Lung Cancers with BRAF Mutations Another Molecularly Defined Subgroup of Patients?
Targeting the VEGF Receptor in Colon Cancer: Lessons Learned from Negative Trials
The Performance of Breast MRI Screening Among Women with BRCA1/2 Mutations
Circulating Tumor Cells in Resectable Colorectal Cancer
Results From a Phase I Trial of TG101348, a Selective JAK2 Inhibitor with Significant Activity in Symptomatic Myelofibrosis Patients
RIBBON-1 Revisited
Noninferiority of Denosumab As Compared With Zolendronic Acid With Respect to the Ability to Delay Skeletal Events in Patients With Solid Tumors and Multiple Myeloma